Kelly Snead
Leidos (United States)(US)Frederick National Laboratory for Cancer Research(US)National Cancer Institute(US)Leidos Biomedical Research Inc. (United States)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, SARS-CoV-2 detection and testing, Protein Kinase Regulation and GTPase Signaling, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses(2021)189 cited
- → Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling(2021)162 cited
- → Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States(2021)138 cited
- → Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays(2020)125 cited
- → Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses(2020)53 cited
- → Structure of the SHOC2–MRAS–PP1C complex provides insights into RAF activation and Noonan syndrome(2022)51 cited